Hangzhou Zhongtai Cryogenic Technology Corporation
300435.SZ · SHZ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 3.26B | 553.59M | 344.99M | 277.96M | 0.73 |
| 2023 FY | 3.05B | 588.92M | 431.63M | 350.06M | 0.92 |
| 2024 FY | 2.72B | 510.07M | -27.03M | -77.96M | -0.20 |
| 2025 FY | 2.75B | 816.94M | 549.08M | 450.36M | 1.17 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 4.68B | 1.86B | 1.28B | 663.29M | 2.82B |
| 2023 FY | 5.42B | 2.23B | 1.67B | 781.03M | 3.17B |
| 2024 FY | 4.54B | 1.50B | 800.01M | 124.44M | 2.98B |
| 2025 FY | 4.65B | 1.15B | 414.21M | 110.31M | 3.42B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 288.24M | -260.75M | 27.49M | -30.26M | 450.93M |
| 2023 FY | 397.88M | -259.88M | 138.00M | -66.45M | 344.32M |
| 2024 FY | 325.06M | -76.75M | 248.31M | -72.72M | -874.01M |
| 2025 FY | 489.00M | -43.56M | 445.44M | -79.27M | -370.39M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 5.08B | 4.46B | — | — | — |
| 2023 FY | 5.48B | 4.59B | — | — | — |
| 2024 FY | 4.61B | 3.93B | — | — | — |
| 2025 FY | 8.55B | 8.25B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 584.18M | 107.10M | 43.32M | 34.47M | 0.09 |
| 2025 Q3 | 809.83M | 327.40M | 230.21M | 200.82M | 0.52 |
| 2025 Q4 | 635.77M | 195.55M | 154.75M | 114.84M | 0.30 |
| 2026 Q1 | 564.97M | 107.92M | 54.00M | 42.55M | 0.11 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 4.45B | 1.27B | 396.96M | 90.13M | 3.11B |
| 2025 Q3 | 4.62B | 1.24B | 462.41M | 98.74M | 3.31B |
| 2025 Q4 | 4.65B | 1.15B | 414.21M | 110.31M | 3.42B |
| 2026 Q1 | 4.59B | 1.06B | 303.28M | 99.62M | 3.46B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 34.44M | -11.10M | 23.34M | -77.74M | -423.17M |
| 2025 Q3 | 236.21M | -10.79M | 225.42M | -260.69K | 65.45M |
| 2025 Q4 | 88.64M | -9.18M | 79.46M | -632.48K | -33.38M |
| 2026 Q1 | 22.06M | -13.99M | 8.07M | -435.90K | -105.25M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 5.86B | 5.55B | — | — | — |
| 2025 Q3 | 7.97B | 7.61B | — | — | — |
| 2025 Q4 | 8.57B | 8.27B | — | — | — |
| 2026 Q1 | 9.93B | 9.73B | — | — | — |